Protagonist Therapeutics, Inc. Financial Ratios — PTGX Stock

Profitability (USD)

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-118.05	-68.32	-28.68	-25.67	-52.44	-27.6	-37.36	-42.78	-26.06	49.91	-18.42
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-58.29	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	48.51	- -
Gross Margin (%)	- -	- -	- -	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	- -	- -	- -	-186.87	-134.98	-34,540.69	-222.05	-457.04	-490.35	-154.46	58.39	-340.85
Operating Margin (%)	- -	- -	- -	-188.89	-136.68	-34,857.58	-225.36	-460.01	-494.24	-156.09	58.2	-343.63
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	92.54	- -
Pretax Margin (%)	- -	- -	- -	-184.2	-128.45	-33,713.42	-226.51	-458.94	-479.26	-131.59	64.32	-281.01
Profit Margin (%)	- -	- -	- -	-184.2	-125.87	-33,414.29	-231.07	-458.94	-479.26	-131.59	63.34	-282.83
Net Income to Common Margin (%)	- -	- -	- -	-184.2	-125.87	-33,414.29	-231.07	-458.94	-479.26	-131.59	63.34	-282.83
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.51	- -
Dvd Payout Ratio (%)	1.3	0.5	1.48	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	17	6	6	4	1	11	10
ST Debt	- -	- -	- -	- -	- -	1	1	2	3	1	1	2
LT Debt	- -	- -	- -	- -	- -	16	4	4	1	- -	10	8
Total Debt/EBITDA	- -	- -	- -	- -	- -	-0.21	-0.09	-0.05	-0.03	-0.01	0.04	-0.07
Net Debt/EBITDA	1.03	0.28	0.65	2.83	1.97	0.29	1.85	0.99	0.96	2.01	-0.38	0.82
Total Debt/EBIT	- -	- -	- -	- -	- -	-0.21	-0.09	-0.05	-0.03	-0.01	0.04	-0.07
Net Debt/EBIT	1	0.27	0.65	2.8	1.95	0.29	1.82	0.98	0.96	1.99	-0.38	0.81
EBITDA to Interest Expense	- -	- -	- -	- -	- -	-472.12	-106.3	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	-477.85	-107.09	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	-476.46	-107.89	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	1	- -	- -	- -	- -	- -
Common Equity/Total Assets	-121.59	-184.68	-68.72	-62.02	-100.72	-140.5	-87.47	-117.74	-216.5	-172.01	-45.72	-70.44
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	19.7	1.61	1.22	0.53	- -	1.53	1.31
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	-7.85	-1.62	-0.91	-0.21	- -	-3.14	-1.75
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	10.17	1.39	1.05	0.46	- -	1.39	1.2
Total Debt/Equity (%)	- -	- -	- -	- -	- -	21.27	2.13	1.95	1.7	0.34	1.61	1.68
Total Debt/Capital (%)	- -	- -	- -	- -	- -	-8.48	-2.14	-1.45	-0.69	-0.19	-3.3	-2.24
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	10.98	1.84	1.68	1.47	0.32	1.46	1.54
Net Debt to Equity	-117.21	-42.26	-24.08	-87.89	-73.09	-29.03	-41.97	-41.22	-58.32	-55.46	-14.4	-20.89
Net Debt/Capital (%)	713.94	-73.39	24.61	51.08	36.92	9.93	29.7	23.46	19.09	23.3	22.78	21.81
EBITDA	-9	-15	-32	-37	-42	-80	-64	-125	-130	-93	254	-157
EBITDA-CapEx	-9	-15	-33	-38	-42	-81	-64	-126	-131	-93	252	-158
Operating Income (Loss)	-9	-15	-33	-38	-42	-81	-65	-126	-131	-94	253	-158

Liquidity (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	6.91	3.81	12.06	3.38	4.93	3.76	7.6	7.43	7.61	16.06	8.84	12.49
Current Ratio	7.34	4.54	12.94	3.55	5.26	4.1	7.84	7.74	7.8	16.71	12.48	12.71
Quick Ratio	7.29	4.04	12.41	3.46	5.16	3.95	7.69	7.55	7.61	16.54	12.39	12.58
CFO/Avg Current Liab	- -	-6.43	-6.27	0.16	-1.45	-1.35	-1.92	-2.56	-2.88	-2.68	5.36	1.24
Common Equity/Total Assets	-121.59	-184.68	-68.72	-62.02	-100.72	-140.5	-87.47	-117.74	-216.5	-172.01	-45.72	-70.44
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	19.7	1.61	1.22	0.53	- -	1.53	1.31
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	-7.85	-1.62	-0.91	-0.21	- -	-3.14	-1.75
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	10.17	1.39	1.05	0.46	- -	1.39	1.2
Total Debt/Equity (%)	- -	- -	- -	- -	- -	21.27	2.13	1.95	1.7	0.34	1.61	1.68
Total Debt/Capital (%)	- -	- -	- -	- -	- -	-8.48	-2.14	-1.45	-0.69	-0.19	-3.3	-2.24
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	10.98	1.84	1.68	1.47	0.32	1.46	1.54
CFO/Total Liabilities	-326.3	-274.05	-465.77	8.98	-185.28	-55.4	-161.57	-226.26	-334.58	-330.15	265.23	107.83
CFO/CapEx	-25.9	-36.05	-86.37	5.81	-102.77	-42.94	-153.89	-97.97	-136.02	-115.33	135.91	36.27
Altman's Z-Score	-3.68	-4.98	12.2	4.41	2.12	-1.37	8.5	18.2	6.29	34.73	22.48	61.55

Working Capital (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	22.1	9.66	0.1	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	16.52	37.79	3,623.93	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	143	368	151	183	693	1,584	535	1,302	2,376	5,552
- Cash & Cash Equivalents	9	4	21	106	82	33	117	124	126	187	97	128
+ Preferred Equity and Hybrid Capital	21	37	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	17	6	6	4	1	11	10
Enterprise Value	11	25	65	224	22	67	394	1,263	301	961	1,968	4,995
Total Capital	8	10	-65	-102	-140	-201	-278	-404	-533	-615	-330	-460
Total Debt/Capital (%)	- -	- -	- -	- -	- -	-8.48	-2.14	-1.45	-0.69	-0.19	-3.3	-2.24
Total Debt / EV	- -	- -	- -	- -	- -	0.26	0.02	- -	0.01	- -	0.01	- -
EV/Sales	- -	- -	- -	11.17	0.7	288.08	13.75	46.17	11.34	16.02	4.53	108.56
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.76	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.79	- -
EV/Cash Flow to Firm	- -	- -	- -	57.86	- -	- -	- -	- -	- -	- -	10.69	86.62
EV/Free Cash Flow to Firm	- -	- -	- -	49.37	- -	- -	- -	- -	- -	- -	10.61	84.3
Diluted Market Cap	- -	- -	143	368	151	183	693	1,584	535	1,302	2,512	5,552
Diluted Enterprise Value	11	33	122	262	68	167	582	1,466	413	1,116	2,426	5,434
EV per Share	1.91	4.26	10.05	12.66	0.97	2.57	11.44	27.27	6.14	16.93	31.97	78.58
TTM Sales	- -	- -	- -	20	31	- -	29	27	27	60	434	46
TTM EBITDA	-9	-15	-32	-37	-42	-80	-64	-125	-130	-93	254	-157
TTM Operating Income	-9	-15	-33	-38	-42	-81	-65	-126	-131	-94	253	-158
TTM Cash Flow to Firm	-8	-14	-30	4	-50	-41	-72	-108	-108	-70	184	58
TTM Free Cash Flow to Firm	-7	-14	-30	5	-49	-40	-71	-107	-107	-70	186	59

Multiples (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-4.83	81.1	-3.04	-4.5	-9.63	-14.84	-4.98	-18.69	13.54	93.7
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.79	- -
Enterprise Value	11	25	65	224	22	67	394	1,263	301	961	1,968	4,995
Low Price	- -	- -	10.02	8	5.49	4.47	5.3	12.8	6.91	10.62	21.43	33.7
EV/Sales	- -	- -	- -	11.17	0.7	288.08	13.75	46.17	11.34	16.02	4.53	108.56
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.76	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.64	- -
Price/Earnings Average	- -	- -	-3.3	-6.99	-6.14	-3.56	-7.88	-12.26	-5.57	-14.14	7.88	-28.07
Price/Earnings High	- -	- -	-4.54	-10.77	-13.77	-5.59	-13.34	-18.65	-14.26	-21.64	10.94	-47.16
Price/Earnings Low	- -	- -	-1.73	-3.83	-3.15	-1.5	-2.76	-4.72	-2.66	-7.64	4.79	-16.46
Price/Book Value	- -	- -	-2.21	-3.62	-1.07	-0.84	-2.44	-3.87	-1	-2.11	-6.98	-11.8
Price/Book Value Average	- -	- -	-1.93	-2.54	-1.7	-1.26	-1.84	-3.76	-1.32	-1.81	-6.37	-7.76
Price/Book Value High	- -	- -	-2.65	-3.92	-3.82	-1.98	-3.11	-5.72	-3.38	-2.77	-8.84	-13.04
Price/Book Value Low	- -	- -	-1.01	-1.39	-0.87	-0.53	-0.64	-1.45	-0.63	-0.98	-3.87	-4.55
Price/Tangible Book Value	- -	- -	1.63	3.05	1.34	2.28	2.48	5.28	2.48	3.87	3.52	9.03
Price/Tangible Book Value Average	- -	- -	1.42	2.14	2.12	3.44	1.86	5.13	3.29	3.32	3.21	5.94
Price/Tangible Book Value High	- -	- -	1.96	3.3	4.76	5.4	3.16	7.8	8.43	5.07	4.46	9.98
Price/Tangible Book Value Low	- -	- -	0.74	1.17	1.09	1.45	0.65	1.98	1.57	1.79	1.95	3.49
Price/Sales	- -	- -	- -	18.34	4.87	790.27	24.22	57.91	20.13	21.69	5.47	120.66
Price/Sales Average	- -	- -	- -	12.87	7.73	1,190.82	18.2	56.27	26.71	18.61	4.99	79.39
Price/Sales High	- -	- -	- -	19.84	17.33	1,868.63	30.82	85.58	68.34	28.48	6.93	133.37
Price/Sales Low	- -	- -	- -	7.06	3.97	501.07	6.37	21.67	12.75	10.05	3.04	46.56
Price/Cash Flow	- -	- -	-4.77	95.05	-3.01	-4.4	-9.57	-14.69	-4.95	-18.53	12.91	96.28
Price/Cash Flow Average	- -	- -	-4.16	66.69	-4.78	-6.62	-7.19	-14.27	-6.57	-15.9	11.78	63.34
Price/Cash Flow High	- -	- -	-5.72	102.82	-10.73	-10.39	-12.17	-21.7	-16.8	-24.33	16.35	106.42
Price/Cash Flow Low	- -	- -	-2.17	36.56	-2.46	-2.79	-2.52	-5.5	-3.13	-8.58	7.16	37.15
Price/Free Cash Flow Average	- -	- -	-4.2	56.9	-4.83	-6.78	-7.24	-14.42	-6.61	-16.04	12.36	61.64
Price/Free Cash Flow High	- -	- -	-5.79	87.73	-10.84	-10.64	-12.25	-21.93	-16.92	-24.54	17.15	103.56
Price/Free Cash Flow Low	- -	- -	-2.2	31.19	-2.48	-2.85	-2.53	-5.55	-3.16	-8.66	7.52	36.15
EV/Sales Average	- -	- -	- -	7.59	5.07	1,121.58	14.31	51.97	22.12	15.52	4.8	76.82
EV/Sales High	- -	- -	- -	14.56	14.68	1,799.39	26.93	81.27	63.75	25.38	6.73	130.81
EV/Sales Low	- -	- -	- -	1.77	1.31	431.82	2.48	17.37	8.16	6.95	2.84	43.99
EV/EBITDA Average	-1.24	-2.26	-3.2	-4.06	-3.76	-3.25	-6.45	-11.37	-4.51	-10.05	8.21	-22.54
EV/EBITDA High	-1.24	-2.26	-4.65	-7.79	-10.87	-5.21	-12.13	-17.78	-13	-16.43	11.53	-38.38
EV/EBITDA Low	-1.24	-2.26	-1.36	-0.95	-0.97	-1.25	-1.12	-3.8	-1.66	-4.5	4.86	-12.91
EV/EBIT Average	-1.21	-2.23	-3.17	-4.02	-3.71	-3.22	-6.35	-11.3	-4.47	-9.94	8.24	-22.36
EV/EBIT High	-1.21	-2.23	-4.6	-7.71	-10.74	-5.16	-11.95	-17.67	-12.9	-16.26	11.56	-38.07
EV/EBIT Low	-1.21	-2.23	-1.35	-0.94	-0.96	-1.24	-1.1	-3.78	-1.65	-4.46	4.88	-12.8
Last Price	- -	- -	21.99	20.8	6.73	7.05	20.16	34.2	10.91	22.93	38.6	87.34
High Price	- -	- -	26.36	22.5	23.97	16.67	25.65	50.54	37.04	30.1	48.89	96.54
Enterprise Value Average	11	33	103	152	157	259	410	1,422	588	931	2,083	3,535
Enterprise Value High	11	33	150	292	454	416	771	2,223	1,694	1,523	2,924	6,019
Enterprise Value Low	11	33	44	36	41	100	71	475	217	417	1,233	2,024

Shares Outstanding	16	17	17	21	23	27	44	48	49	58	61	63
Diluted Weighted Avg Shares	6	6	7	18	22	26	34	46	49	57	65	64
Basic Weighted Avg Shares	6	6	7	18	22	26	34	46	49	57	62	64
Revenue per Share	- -	- -	- -	1.13	1.38	0.01	0.83	0.59	0.54	1.06	7.06	0.72
EBITDA per Share	-1.54	-2.47	-4.98	-2.12	-1.87	-3.08	-1.85	-2.7	-2.66	-1.63	4.12	-2.47
Operating Income per Share	-1.58	-2.51	-5.02	-2.14	-1.89	-3.11	-1.88	-2.72	-2.68	-1.65	4.11	-2.49
Basic EPS, GAAP	-1.91	-2.54	-5.8	-2.09	-1.74	-2.98	-1.92	-2.71	-2.6	-1.39	4.47	-2.05
Basic EPS from Cont Ops	-1.88	-2.52	-5.72	-2.09	-1.74	-2.98	-1.92	-2.71	-2.6	-1.39	4.47	-2.05
Diluted EPS, GAAP	-1.91	-2.54	-5.8	-2.09	-1.74	-2.98	-1.92	-2.71	-2.6	-1.39	4.23	-2.05
Diluted EPS from Cont Ops	-1.88	-2.52	-5.72	-2.09	-1.74	-2.98	-1.92	-2.71	-2.6	-1.39	4.23	-2.05
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.32	-2.44	-4.61	0.22	-2.23	-1.6	-2.11	-2.33	-2.2	-1.24	2.99	0.91
Free Cash Flow per Basic Share	-1.37	-2.51	-4.66	0.18	-2.26	-1.64	-2.12	-2.35	-2.22	-1.25	2.97	0.88
Cash & Equivalents per Share	1.58	2.03	11.94	8.14	5.76	5.14	8.89	7.06	4.84	6.02	6.8	8.92
Book Value per Share	-2.13	-4.66	-9.93	-5.74	-6.28	-8.41	-8.25	-8.84	-10.94	-10.85	-5.53	-7.4
Tangible Book Value per Share	-2.14	-4.66	13.47	6.82	5.03	3.09	8.13	6.48	4.4	5.93	10.97	9.67

Protagonist Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)